Plain-English translation of NCT06689605 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ovarian Cancer research guide →This trial is evaluating a minimally invasive procedure called an ultrasound-guided tru-cut biopsy, which uses a special needle to collect a small tissue sample from a suspected ovarian tumor. Researchers want to confirm that this procedure can reliably diagnose ovarian cancer, is safe for patients, and provides good-quality tissue samples for pathologists to examine. The study will also ask patients about their experience with the procedure.
Ovarian cancer is often diagnosed late, when it has already spread. Before surgery or chemotherapy, doctors need to know the exact type and stage of cancer to plan the best treatment. This biopsy method may offer a safer, faster way to get a tissue diagnosis without major surgery, helping patients start treatment sooner.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will undergo an ultrasound-guided needle biopsy performed by experienced specialists at the gynecological oncology center. The procedure involves using ultrasound imaging to guide a special needle to collect tiny tissue samples from the suspicious area. After the procedure, you will be asked to complete a brief survey about your experience, comfort level, and any side effects you may have noticed.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Czechia
Enrollment target
~30 participants
Started
January 2025
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Munachiso Iheme Ndukwe, MD
University Hospital Hradec Kralove
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.